Valuation: ResMed Inc.

Market Cap 31.94B 28.54B 26.21B 23.81B 44.7B 3,026B 45.83B 313B 126B 1,597B 120B 117B 5,062B P/E 2027 *
19x
P/E 2028 * 17.4x
Enterprise Value 31.05B 27.74B 25.48B 23.14B 43.46B 2,941B 44.55B 304B 122B 1,552B 117B 114B 4,920B EV / Sales 2027 *
5.32x
EV / Sales 2028 * 4.91x
Free-Float
73.23%
Yield 2027 *
1.18%
Yield 2028 * 1.26%
1 day+0.33%
1 week-4.84%
Current month-5.86%
1 month+5.82%
3 months+8.89%
6 months+15.44%
Current year-6.98%
1 week 32.53
Extreme 32.53
37.67
1 month 31.52
Extreme 31.52
37.67
Current year 25.5
Extreme 25.5
39.1
1 year 25.5
Extreme 25.5
39.94
3 years 22.19
Extreme 22.19
45.25
5 years 21.14
Extreme 21.14
45.25
10 years 7.15
Extreme 7.15
45.25
Manager TitleAgeSince
Chief Executive Officer 54 28/02/2013
Director of Finance/CFO 41 03/05/2026
Chief Tech/Sci/R&D Officer - 31/01/2024
Director TitleAgeSince
Director/Board Member 78 31/12/2004
Chairman 54 24/01/2023
Chairman 84 31/05/1989
Change 5-day change 1-year change 3-year change Capi.($)
+0.33%-4.84% - - 31.94B
+2.30%+0.77%+23.63%+53.57% 259B
+0.94%-0.81%+7.50%+16.29% 162B
+0.89%-1.15%-19.01%+58.25% 153B
-1.85%-3.46%-55.88%-17.19% 63.04B
+2.39%+4.37%-9.75%-6.56% 54.01B
+2.07%+4.81%+14.59%+41.93% 54.87B
-1.23%-3.27%+3.58%+55.82% 49.09B
+2.02%-1.14%+21.27%+60.94% 49.47B
+2.31%-1.85%+33.08%+76.55% 45.18B
Average +1.87%-0.64%+2.11%+37.73% 98.79B
Weighted average by Cap. +1.92%-0.55%+4.38%+39.90%

Financials

2027 *2028 *
Net sales 5.84B 5.21B 4.79B 4.35B 8.17B 553B 8.37B 57.17B 23B 292B 21.91B 21.44B 925B 6.21B 5.55B 5.1B 4.63B 8.69B 588B 8.91B 60.82B 24.47B 310B 23.31B 22.81B 984B
Net income 1.69B 1.51B 1.39B 1.26B 2.37B 160B 2.43B 16.57B 6.67B 84.59B 6.35B 6.21B 268B 1.82B 1.62B 1.49B 1.35B 2.54B 172B 2.61B 17.8B 7.16B 90.87B 6.82B 6.68B 288B
Net Debt -892M -797M -732M -665M -1.25B -84.49B -1.28B -8.74B -3.51B -44.59B -3.35B -3.28B -141B -1.48B -1.32B -1.21B -1.1B -2.07B -140B -2.12B -14.49B -5.83B -73.94B -5.55B -5.43B -234B
Projected Income Statement - Annual - ResMed Inc.
Logo ResMed Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.2%); - masks (36.9%); - software as a service (11.9%): residential care management software solutions. At the end of June 2026, the group had 9 production sites located in the United States (4), Australia, China, Singapore, Malaysia and France. The United States accounts for 63% of net sales.
Employees
11,370
Date Price Change Volume
04/11/26 A$33.43 +0.33% 3,504,602
03/11/26 A$33.32 -0.42% 2,906,749
02/11/26 A$33.46 -5.77% 4,025,488
30/10/26 A$35.51 +0.37% 2,628,627
29/10/26 A$35.38 +0.71% 1,912,360
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - ResMed Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
227.08USD
Average target price
265.11USD
Spread / Average Target
+16.75%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ResMed Inc.